Non-profit generics manufacturer Civica Rx says it will invest $124.5m with strategic partner Phlow Corporation to build a 120,000 sq ft (11,150 sq m) sterile injectable manufacturing facility in Petersburg, Virginia, for production of essential medicines, including those used in hospitals for the treatment of COVID-19.
With construction already underway, Civica expects to begin operations within three years. “A talented, highly experienced plant leadership team is...





